E-ISSN 2218-6050 | ISSN 2226-4485
 

Research Article


Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs

Hirona Ueno, Yuta Nishiyama, Takuya Maruo, Yohei Fukuda, Takayuki Katayama, Shinichiro Yoda, Kotaro Nishi, Hideki Kayanuma.


Abstract
Background:
Despite an initial favorable response to hypofractionated radiotherapy (RT), intranasal neoplasia has a poor long-term prognosis. Re-irradiation (re-RT) has been shown to result in clinical remission in dogs with recurrent intranasal tumors. Hypofractionated re-RT is indicated in cases of recurrence.

Aim:
This study aimed to investigate the response of patients with recurrent intranasal tumors who were initially treated with repeated hypofractionated RT.

Methods:
Medical records of dogs with intranasal tumors that relapsed after undergoing hypofractionated RT at Azabu University Veterinary Teaching Hospital and who underwent re-RT between 2008 and 2022 were retrospectively analyzed.

Results:
Among the 30 dogs included, 20 had adenocarcinomas. Eleven patients underwent second re-irradiation, and five patients underwent third re-irradiation. The median total isocenter dose and total number of fractions were 56 Gy (range, 37.5–102) and 8 fractions (range, 5–14), respectively. The first, second, and third progression-free intervals (PFI) were 315 (n = 30), 185 (n = 11), and 218 days (n = 4), respectively. Overall survival (OS) was 504 days (n = 30). Adverse events such as alopecia (n = 7), white hair (n = 8), cataracts (n = 9), pigmentation (n = 5), keratitis (n = 3), and corneal ulceration (n = 1) were limited to grades 1 and 2. The medians of the first PFI for one course and two or more courses of re-RT were 298 and 331 days, respectively, indicating no significant differences between the groups. The OS after two or more courses of re-RT (758 days) was significantly longer than after one course of re-RT alone (414 days) (P = 0.048). However, the cases were not randomized and most of the tumor types were adenocarcinomas.

Conclusion:
Since it is expected to prolong survival time with few life-threatening adverse events, the findings of the present study suggest that hypofractionated re-RT can be used in dogs with recurrent intranasal tumors initially treated with hypofractionated RT. Therefore, repeated hypofractionated re-RT may be a reasonable option for young dogs with a good initial response and recurrent intranasal tumors.

Key words: Dog, Hypofractionated radiotherapy, Intranasal tumor, Recurrence, Re-irradiation


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Hirona Ueno
Articles by Yuta Nishiyama
Articles by Takuya Maruo
Articles by Yohei Fukuda
Articles by Takayuki Katayama
Articles by Shinichiro Yoda
Articles by Kotaro Nishi
Articles by Hideki Kayanuma
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ueno H, Nishiyama Y, Maruo T, Fukuda Y, Katayama T, Yoda S, Nishi K, Kayanuma H. Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. Open Vet J. 2025; 15(2): 827-834. doi:10.5455/OVJ.2025.v15.i2.32


Web Style

Ueno H, Nishiyama Y, Maruo T, Fukuda Y, Katayama T, Yoda S, Nishi K, Kayanuma H. Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. https://www.openveterinaryjournal.com/?mno=226692 [Access: March 12, 2025]. doi:10.5455/OVJ.2025.v15.i2.32


AMA (American Medical Association) Style

Ueno H, Nishiyama Y, Maruo T, Fukuda Y, Katayama T, Yoda S, Nishi K, Kayanuma H. Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. Open Vet J. 2025; 15(2): 827-834. doi:10.5455/OVJ.2025.v15.i2.32



Vancouver/ICMJE Style

Ueno H, Nishiyama Y, Maruo T, Fukuda Y, Katayama T, Yoda S, Nishi K, Kayanuma H. Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. Open Vet J. (2025), [cited March 12, 2025]; 15(2): 827-834. doi:10.5455/OVJ.2025.v15.i2.32



Harvard Style

Ueno, H., Nishiyama, . Y., Maruo, . T., Fukuda, . Y., Katayama, . T., Yoda, . S., Nishi, . K. & Kayanuma, . H. (2025) Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. Open Vet J, 15 (2), 827-834. doi:10.5455/OVJ.2025.v15.i2.32



Turabian Style

Ueno, Hirona, Yuta Nishiyama, Takuya Maruo, Yohei Fukuda, Takayuki Katayama, Shinichiro Yoda, Kotaro Nishi, and Hideki Kayanuma. 2025. Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. Open Veterinary Journal, 15 (2), 827-834. doi:10.5455/OVJ.2025.v15.i2.32



Chicago Style

Ueno, Hirona, Yuta Nishiyama, Takuya Maruo, Yohei Fukuda, Takayuki Katayama, Shinichiro Yoda, Kotaro Nishi, and Hideki Kayanuma. "Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs." Open Veterinary Journal 15 (2025), 827-834. doi:10.5455/OVJ.2025.v15.i2.32



MLA (The Modern Language Association) Style

Ueno, Hirona, Yuta Nishiyama, Takuya Maruo, Yohei Fukuda, Takayuki Katayama, Shinichiro Yoda, Kotaro Nishi, and Hideki Kayanuma. "Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs." Open Veterinary Journal 15.2 (2025), 827-834. Print. doi:10.5455/OVJ.2025.v15.i2.32



APA (American Psychological Association) Style

Ueno, H., Nishiyama, . Y., Maruo, . T., Fukuda, . Y., Katayama, . T., Yoda, . S., Nishi, . K. & Kayanuma, . H. (2025) Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs. Open Veterinary Journal, 15 (2), 827-834. doi:10.5455/OVJ.2025.v15.i2.32